Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Capitol Hill Fragrance Day

This article was originally published in The Rose Sheet

Executive Summary

The Cosmetic, Toiletry and Fragrance Association hosted "Fragrance Day" for Congressional Members and staff on Capitol Hill June 1, showcasing the "scientific, technological and physiological elements involved in creating fragrances," association reports. CTFA partnered with Firmenich and the Fragrance Foundation's Sense of Smell Institute to "educate members and staff about fragrance development, using visual exhibits and interactive displays. Estee Lauder Pleasures and Ralph Lauren Romance were among fragrances displayed during the event. CTFA President Pam Bailey has stressed the importance of Congressional outreach (1"The Rose Sheet" Jan. 16, 2006, p. 4)...

You may also be interested in...



CTFA Stresses Importance Of FD&C Act In Congressional Outreach

The Cosmetic, Toiletry and Fragrance Association will work this year to communicate to Congress the value of the FD&C Act in regulating cosmetic safety, according to CTFA President Pam Bailey

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.

Metsera Launches As New Obesity Contender Flush With $290m

Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture. 

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013976

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel